{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:44:56Z","timestamp":1788443096925,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.cbi.2023.110628","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T15:10:37Z","timestamp":1689088237000},"page":"110628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Metabolic activation and cytotoxicity of metaxalone mediated by cytochrome P450 enzymes and sulfotransferases"],"prefix":"10.1016","volume":"382","author":[{"given":"He","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guode","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdie","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8187-2147","authenticated-orcid":false,"given":"Jiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2023.110628_bib1","first-page":"974","article-title":"Development of novel crystal forms of metaxalone for solubility enhancement","volume":"82","author":"Aziz","year":"2020","journal-title":"Indian J. Pharmaceut. Sci."},{"key":"10.1016\/j.cbi.2023.110628_bib2","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.clinthera.2004.09.008","article-title":"Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone","volume":"26","author":"Toth","year":"2004","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.cbi.2023.110628_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fluid.2015.09.013","article-title":"Solubility correlation and thermodynamic analysis of two forms of Metaxalone in different pure solvents","volume":"409","author":"Hong","year":"2016","journal-title":"Fluid Phase Equil."},{"key":"10.1016\/j.cbi.2023.110628_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/0960327108098150","article-title":"Adult metaxalone ingestions reported to Texas poison control centers, 2000-2006","volume":"29","author":"Forrester","year":"2010","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.cbi.2023.110628_bib5","first-page":"433","article-title":"A study of metaxalone (Skelaxin) vs. placebo in acute musculoskeletal disorders: a cooperative study","volume":"18","author":"Dent","year":"1975","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.cbi.2023.110628_bib6","first-page":"677","article-title":"A second look at a skeletal muscle relaxant: a double-blind study of metaxalone","volume":"6","author":"Fathie","year":"1964","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.cbi.2023.110628_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jat\/bkv008","article-title":"A rare fatality attributed solely to metaxalone","volume":"39","author":"Curtis","year":"2015","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.cbi.2023.110628_bib8","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1520\/JFS2002286","article-title":"Polydrug fatality involving metaxalone","volume":"48","author":"Gruszecki","year":"2003","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.cbi.2023.110628_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.forsciint.2004.07.017","article-title":"A fatality involving metaxalone","volume":"149","author":"Moore","year":"2005","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.cbi.2023.110628_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/jat\/28.6.537","article-title":"Metaxalone (skelaxin (R))-related death","volume":"28","author":"Poklis","year":"2004","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.cbi.2023.110628_bib11","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1021\/acs.chemrestox.8b00117","article-title":"CYP3A activation and glutathione depletion aggravate emodin-induced liver injury","volume":"31","author":"Jiang","year":"2018","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2023.110628_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/03602532.2011.605791","article-title":"Metabolic activation in drug-induced liver injury","volume":"44","author":"Leung","year":"2012","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.cbi.2023.110628_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1021\/acs.chemrestox.5b00501","article-title":"Role of metabolic activation in 8-epidiosbulbin E acetate-induced liver injury: mechanism of action of the hepatotoxic furanoid","volume":"29","author":"Lin","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2023.110628_bib14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1021\/jm00321a004","article-title":"Metabolism of metaxalone","volume":"9","author":"Bruce","year":"1966","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110628_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/00498259609046709","article-title":"Induction of cytochrome P450 isoenzymes in cultured precision-cut rat and human liver slices","volume":"26","author":"Lake","year":"1996","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cbi.2023.110628_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1021\/jm00349a001","article-title":"Metabolic activation and drug toxicity","volume":"25","author":"Nelson","year":"1982","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110628_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/toxsci\/kfj061","article-title":"Human sulfotransferases and their role in chemical metabolism","volume":"90","author":"Gamage","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2023.110628_bib18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1096\/fasebj.11.4.9068609","article-title":"Enzymology of human cytosolic sulfotransferases","volume":"11","author":"Falany","year":"1997","journal-title":"Faseb. J."},{"key":"10.1016\/j.cbi.2023.110628_bib19","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1124\/dmd.114.059261","article-title":"Cytochrome P450 - mediated metabolic activation of diosbulbin B","volume":"42","author":"Lin","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2023.110628_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/00498254.2018.1432087","article-title":"Metabolic characteristics of Tanshinone I in human liver microsomes and S9 subcellular fractions","volume":"49","author":"Li","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cbi.2023.110628_bib21","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1021\/acs.chemrestox.2c00054","article-title":"Metabolic activation of gemfibrozil mediated by cytochrome P450 enzymes and sulfotransferases","volume":"35","author":"Zhao","year":"2022","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2023.110628_bib22","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1021\/acs.chemrestox.1c00060","article-title":"Metabolic activation and cytotoxicity of labetalol hydrochloride mediated by sulfotransferases","volume":"34","author":"Yang","year":"2021","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2023.110628_bib23","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/0006-2952(94)90301-8","article-title":"2,6-Dichloro-4-nitrophenol (DCNP), an alternate-substrate inhibitor of phenolsulfotransferase","volume":"47","author":"Seah","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2023.110628_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF03190428","article-title":"Sulfation of indoxyl by human and rat aryl (phenol) sulfotransferases to form indoxyl sulfate","volume":"27","author":"Banoglu","year":"2002","journal-title":"Eur. J. Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.cbi.2023.110628_bib25","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1080\/00498254.2021.1913666","article-title":"Metabolic activation of aegeline mediated by CYP2C19","volume":"51","author":"Tian","year":"2021","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cbi.2023.110628_bib26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2174\/138920005774832632","article-title":"A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction","volume":"6","author":"Sivaraman","year":"2005","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.cbi.2023.110628_bib27","first-page":"897","article-title":"Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro","volume":"29","author":"Zhang","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2023.110628_bib28","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1080\/00498254.2021.1938290","article-title":"Metabolic activation of zolmitriptan mediated by CYP2D6","volume":"51","author":"Han","year":"2021","journal-title":"Xenobiotica"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723002958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723002958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T20:41:42Z","timestamp":1736368902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279723002958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":28,"alternative-id":["S0009279723002958"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110628","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic activation and cytotoxicity of metaxalone mediated by cytochrome P450 enzymes and sulfotransferases","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110628"}}